» Articles » PMID: 24550985

Updates in Reproduction Coming from the Endocannabinoid System

Overview
Publisher Wiley
Specialty Endocrinology
Date 2014 Feb 20
PMID 24550985
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

The endocannabinoid system (ECS) is an evolutionarily conserved master system deeply involved in the central and local control of reproductive functions in both sexes. The tone of these lipid mediators-deeply modulated by the activity of biosynthetic and hydrolyzing machineries-regulates reproductive functions from gonadotropin discharge and steroid biosynthesis to the formation of high quality gametes and successful pregnancy. This review provides an overview on ECS and reproduction and focuses on the insights in the regulation of endocannabinoid production by steroids, in the regulation of male reproductive activity, and in placentation and parturition. Taken all together, evidences emerge that the activity of the ECS is crucial for procreation and may represent a target for the therapeutic exploitation of infertility.

Citing Articles

Exploring β-caryophyllene: a non-psychotropic cannabinoid's potential in mitigating cognitive impairment induced by sleep deprivation.

Lim C, Ogawa S, Kumari Y Arch Pharm Res. 2024; 48(1):1-42.

PMID: 39653971 DOI: 10.1007/s12272-024-01523-z.


Editorial: Multifaceted cannabinoids: regulators of normal and pathological function in metabolic and endocrine organs, volume II.

Meccariello R, Aseer K, Kabir M, Santoro A Front Endocrinol (Lausanne). 2024; 15:1503017.

PMID: 39493780 PMC: 11528542. DOI: 10.3389/fendo.2024.1503017.


Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication.

Haddad N, De Jesus L, Serpa M, Van De Bilt M, Talib L, Costa A Eur Arch Psychiatry Clin Neurosci. 2024; 275(2):545-553.

PMID: 38502208 DOI: 10.1007/s00406-024-01788-x.


The interplay between kisspeptin and endocannabinoid systems modulates male hypothalamic and gonadic control of reproduction .

Marino M, DAuria R, Mele E, Pastorino G, Di Pietro P, DAngelo S Front Endocrinol (Lausanne). 2023; 14:1269334.

PMID: 37900144 PMC: 10602894. DOI: 10.3389/fendo.2023.1269334.


Molecular Advances on Cannabinoid and Endocannabinoid Research.

Meccariello R Int J Mol Sci. 2023; 24(16).

PMID: 37628940 PMC: 10454180. DOI: 10.3390/ijms241612760.


References
1.
Wang H, Xie H, Dey S . Loss of cannabinoid receptor CB1 induces preterm birth. PLoS One. 2008; 3(10):e3320. PMC: 2553193. DOI: 10.1371/journal.pone.0003320. View

2.
Wang H, Matsumoto H, Guo Y, Paria B, Roberts R, Dey S . Differential G protein-coupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation. Proc Natl Acad Sci U S A. 2003; 100(25):14914-9. PMC: 299852. DOI: 10.1073/pnas.2436379100. View

3.
Elphick M . The evolution and comparative neurobiology of endocannabinoid signalling. Philos Trans R Soc Lond B Biol Sci. 2012; 367(1607):3201-15. PMC: 3481536. DOI: 10.1098/rstb.2011.0394. View

4.
Cacciola G, Chioccarelli T, Altucci L, Ledent C, Mason J, Fasano S . Low 17beta-estradiol levels in CNR1 knock-out mice affect spermatid chromatin remodeling by interfering with chromatin reorganization. Biol Reprod. 2013; 88(6):152. DOI: 10.1095/biolreprod.112.105726. View

5.
Chianese R, Ciaramella V, Scarpa D, Fasano S, Pierantoni R, Meccariello R . Anandamide regulates the expression of GnRH1, GnRH2, and GnRH-Rs in frog testis. Am J Physiol Endocrinol Metab. 2012; 303(4):E475-87. DOI: 10.1152/ajpendo.00086.2012. View